News Search Results
Feb 27, 2026, 08:11 ET Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata
Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review. Journal of the American Academy of Dermatology, 85(1), 162–175.
More news about: Eli Lilly and Company
Feb 24, 2026, 16:15 ET HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASES
meaningful reductions in pain and itchingZero dose-limiting toxicities observed across the entire trial to dateAt the American Academy of Dermatology Annual Meeting, a case study demonstrated complete lesion and symptom resolution after just one week of twice-daily application in a metastatic
More news about: Hoth Therapeutics, Inc.
Feb 19, 2026, 08:14 ET SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma
judgment," said Dr. Darrell Rigel, MD, Clinical Professor of Dermatology at the New York University (NYU), and Past President of the American Academy of Dermatology. "While visual assessment and dermoscopy have long been shown to improve melanoma detection rates, our published clinical research demonstrates
More news about: SciBase
Feb 18, 2026, 06:45 ET Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight
associated with poorer treatment response to biologics at 6 months: A prospective analysis in Corrona Psoriasis Registry. Journal of the American Academy of Dermatology, Volume 86, Issue 1, 68 - 76.4 Lebwohl M, Strober B, Menter A, et al. Phase 3 studies comparing brodalumab with ustekinumab
More news about: Eli Lilly and Company
Jan 22, 2026, 10:07 ET Ezderm Unveils Platform Evolution: Introduces 'Eve' AI Ecosystem and 'Compass' Clinical Interface
Debuting this March at the 2026 American Academy of Dermatology (AAD) Annual Meeting, Eve is a proprietary AI ecosystem fully embedded in the Ezderm EHR and Practice Management platform. From encounter
More news about: Ezderm, LLC
Jan 20, 2026, 07:00 ET Clinical Trial Demonstrates Accurate Non-Invasive Detection of In Vivo Biologic Activity in Melanomas by the Orlucent® Skin Fluorescent Imaging System
solutions for the non-invasive detection of melanoma activity, were published in the February edition of the peer-reviewed Journal of the American Academy of Dermatology (JAAD) International.
More news about: Orlucent, Inc.
Jan 07, 2026, 17:31 ET Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
Therapeutics announced the presentation of two head-to-head preclinical studies of its oral psoriasis treatment candidate, SFA-002, at the American Academy of Dermatology Annual Meeting in Orlando, Florida.In March 2025, Boehringer Ingelheim presented new post-hoc exploratory analyses from
More news about: DelveInsight Business Research, LLP
Jan 06, 2026, 11:40 ET Joint statement from the American Academy of Dermatology Association and the New York State Society of Dermatology and Dermatologic Surgery on New York City Council medspa investigation
the AADAHeadquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. A sister organization to the Academy, the American Academy of Dermatology Association is the resource for government
More news about: American Academy of Dermatology Association
Jan 06, 2026, 08:48 ET Leaf & Mineral™ Helps With Dry Skin When Cleaning in Cold Weather
trickle-down effect that does more than amp up energy bills and make it hard to get to work in the morning. It could also dry out the skin. The American Academy of Dermatology
More news about: Leaf & Mineral
Dec 18, 2025, 02:00 ET New Data from SkylineDx Demonstrates Merlin CP-GEP Test's Superior Melanoma Risk Stratification
newly published analysis4 in Journal of American Academy of Dermatology about early-stage T1a melanoma showed that Merlin CP-GEP High-Risk reliably identifies patients with >10% risk of SLNB metastasis, suggesting
More news about: SkylineDx
Dec 15, 2025, 07:00 ET Laser by Aleya Expands Client Education and Personalized Care to Support Women's Skin Health at Every Stage
understand their treatment options beyond surface-level aesthetics.Industry ContextAccording to a 2023 report by the American Academy of Dermatology, conditions like PCOS and menopause can cause significant changes in hair growth and skin barrier stability, yet many women report receiving
More news about: Laser by Aleya
Dec 11, 2025, 11:09 ET American Academy of Dermatology Association Statement on FDA Proposal for New Sunscreen Ingredient
Statement from Susan C. Taylor, MD, FAAD, President, American Academy of DermatologyROSEMONT, Ill., Dec. 11, 2025 /PRNewswire/ -- The American Academy of Dermatology Association applauds the Food and Drug Administration
More news about: American Academy of Dermatology Association
Nov 25, 2025, 22:51 ET FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)
label update.The long-term results from the pivotal open-label study of UNLOXCYT in aCSCC were published in the Journal of the American Academy of Dermatology (JAAD), further validating the strength of the data.MUMBAI, India and PRINCETON, N.J.,
More news about: Sun Pharma
Nov 05, 2025, 10:44 ET Laser by Aleya Introduces Stress-Responsive Skin Consultation to Help Clients Manage Inflammation, Sensitivity, and Breakouts
control. Scientific Context According to the American Academy of Dermatology, chronic stress can disrupt the skin's immune response, delay healing, and contribute to conditions like acne, eczema, and psoriasis.
More news about: Laser by Aleya
Oct 29, 2025, 09:06 ET Top Cincinnati Dermatologist Dr. Kristine Zitelli Named 2026 Cincinnati Magazine Top Doctor for Dermatology
Medicine Award from the Department of Dermatology. She is board-certified by the American Board of Dermatology and is a Fellow of the American Academy of Dermatology (FAAD). In addition to her ten consecutive years as a Cincinnati Magazine Top Doctor (2017-2026), Dr. Zitelli was
More news about: Queen City Dermatology
Oct 28, 2025, 12:17 ET A Dermatologist's Guide to Skincare from Growing Up to Glowing Up
About the AAD Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more
More news about: American Academy of Dermatology
Oct 24, 2025, 06:45 ET Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
strong recommendation and high certainty of evidence that can be used with or without topicals, according to guidelines published by the American Academy of Dermatology (AAD),** which are used as a key consideration for dermatologists and managed care providers. Lilly continues to
More news about: Eli Lilly and Company
Oct 24, 2025, 06:45 ET Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
36-week results from the BRAVE-AA-PEDS trial previously presented at the 2025 American Academy of Dermatology (AAD) annual meeting in March. "For nearly half of the people with severe alopecia areata, the disease starts before
More news about: Eli Lilly and Company
Oct 14, 2025, 07:30 ET Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
Cutaneous Lymphoma Foundation and a member of the U.S. Cutaneous Lymphoma Consortium. She is an editorial reviewer for the Journal of the American Academy of Dermatology. Youn Kim, MD
More news about: Soligenix
Oct 07, 2025, 17:31 ET AHR Agonists Market Trends Signal Promising Growth in Immunology and Dermatology Therapeutics | DelveInsight
the Phase III ADORING 3 open-label extension study of VTAMA cream, 1%, in patients aged 2 and older with atopic dermatitis at the American Academy of Dermatology (AAD) Annual Meeting. The data showed that patients who achieved treatment success maintained mild disease activity over an average 80-day
More news about: DelveInsight Business Research, LLP
Oct 01, 2025, 08:35 ET skinbetter science® Launches Mystro Revive Renewing Serum for Perimenopausal and Menopausal Skin
According to the American Academy of Dermatology,
More news about: skinbetter science
Sep 22, 2025, 17:31 ET Prurigo Nodularis market to exhibit growth at a CAGR of 23.2% (2020-2034), driven by strong uptake of DUPIXENT, recent approval of NEMLUVIO, promising JAK and OX40 inhibitors in the Pipeline, along with rising prevalence | DelveInsight
clinical trials (TRuE-PN1 and TRuE-PN2 studies) evaluating ruxolitinib cream 1.5% (OPZELURA) in patients with prurigo nodularis at the 2025 American Academy of Dermatology (AAD) Annual Meeting.According to the Q2 2025 Kyowa Kirin corporate presentation, Phase III completion for rocatinlimab
More news about: DelveInsight Business Research, LLP
Sep 18, 2025, 09:00 ET LA ROCHE-POSAY TEAMS UP WITH GLOBAL GAMING PHENOMENON NINJA FOR GAMING FOR CAUSE, A 24-HOUR LIVESTREAM CHARITY EVENT TO CHAMPION SKIN CANCER AWARENESS AND PREVENTION
[email protected] 1 Holman, Dawn M et al. "Patterns of sunscreen use on the face and other exposed skin among US adults." Journal of the American Academy of Dermatology vol. 73,1 (2015): 83-92.e1. doi:10.1016/j.jaad.2015.02.11122 Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella
More news about: La Roche-Posay
Sep 17, 2025, 08:00 ET Icotrokinra shows superiority to deucravacitinib in first reported head-to-head trials reinforcing promise of novel targeted oral peptide for treatment of plaque psoriasis
presented at the American Academy of Dermatology 2025 Congress.3"The long-term data from ICONIC-LEAD continue to demonstrate the potential of icotrokinra to address
More news about: Johnson & Johnson
Aug 14, 2025, 17:31 ET Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight
Therapeutics announced the presentation of two head-to-head preclinical studies of its oral psoriasis treatment candidate, SFA-002, at the American Academy of Dermatology Annual Meeting in Orlando, Florida.In March 2025, SFA Therapeutics
More news about: DelveInsight Business Research, LLP